Skip to main content

IBD

2
Pipeline Programs
5
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Pharmacosmos
PharmacosmosDenmark - Holbaek
1 program
1
Iron IsomaltosidePhase 41 trial
Active Trials
NCT03466983Completed97Est. May 2020
AbbVie
AbbVieNORTH CHICAGO, IL
2 programs
1
Adalimumab-800CWPhase 21 trial
Breath TestN/A1 trial
Active Trials
NCT04827368Active Not Recruiting292Est. Jun 2026
NCT03938701Recruiting36Est. Aug 2026
Takeda
TakedaTOKYO, Japan
1 program
90Second IBDN/A1 trial
Active Trials
NCT05686135Withdrawn0Est. Apr 2024
Medtronic
MedtronicNJ - Phillipsburg
1 program
Capsule endoscopyN/A1 trial
Active Trials
NCT02182947Completed45Est. Dec 2018
Boomerang Medical
Boomerang MedicalCA - Mountain View
1 program
NeuromodulationN/A1 trial
Active Trials
NCT05414955Completed40Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PharmacosmosIron Isomaltoside
AbbVieAdalimumab-800CW
Takeda90Second IBD
Boomerang MedicalNeuromodulation
AbbVieBreath Test
MedtronicCapsule endoscopy

Clinical Trials (6)

Total enrollment: 510 patients across 6 trials

NCT03466983PharmacosmosIron Isomaltoside

A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease

Start: May 2018Est. completion: May 202097 patients
Phase 4Completed
NCT03938701AbbVieAdalimumab-800CW

Fluorescence Imaging of IBD and RA Using Adalimumab-800CW

Start: Aug 2024Est. completion: Aug 202636 patients
Phase 2Recruiting
NCT05686135Takeda90Second IBD

90Second IBD for the Improvement of Self Efficacy and Quality of Life in Inflammatory Bowel Disease Patients

Start: Jun 2023Est. completion: Apr 20240
N/AWithdrawn

Boom-IBD Clinical Trial

Start: Oct 2022Est. completion: Dec 202440 patients
N/ACompleted

Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease

Start: Mar 2021Est. completion: Jun 2026292 patients
N/AActive Not Recruiting
NCT02182947MedtronicCapsule endoscopy

Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children

Start: Aug 2012Est. completion: Dec 201845 patients
N/ACompleted

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 510 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.